Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. (Q52576378)
Jump to navigation
Jump to search
scientific article published in January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. |
scientific article published in January 2007 |
Statements
Cell cycle phenotype-based optimization of G2-abrogating peptides yields CBP501 with a unique mechanism of action at the G2 checkpoint. (English)
1 reference
Shi-Ken Sha
1 reference
Takuji Sato
1 reference
Hidetaka Kobayashi
1 reference
Machiyo Ishigaki
1 reference
Sayaka Yamamoto
1 reference
Hitoshi Sato
1 reference
Asako Takada
1 reference
Sigetosi Nakajyo
1 reference
Yasuo Mochizuki
1 reference
Fong-Chi Cheng
1 reference
Takashi Okura
1 reference
Ryohei Kimura
1 reference
Donald W Kufe
1 reference
Daniel D Vonhoff
1 reference
Takumi Kawabe
1 reference
1 January 2007
1 reference
6
1 reference
147-153
1 reference
1
1 reference